Back to
Virtu Financial LLC
EGRX2 quarters
Position history for
Virtu Financial LLC's holdings in EAGLE PHARMACEUTICALS INC
No. Virtu Financial exited its EGRX (Eagle Pharmaceuticals) position in Q4 2024. Its Q3 2024 13F listed 12,890 shares worth $48,000. Virtu Financial first reported EGRX in Q3 2024 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$48,000
Total Shares Change
-12,890
Quarter-by-Quarter History
Other major holders of EGRX: Janus Henderson Group Ltd.